LivaNova (LIVN) Competitors $50.22 +0.17 (+0.34%) (As of 10:39 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LIVN vs. CNMD, INMD, BLFS, NTUS, HAE, PEN, GKOS, BLCO, INSP, and PRCTShould you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include CONMED (CNMD), InMode (INMD), BioLife Solutions (BLFS), Natus Medical (NTUS), Haemonetics (HAE), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical" sector. LivaNova vs. CONMED InMode BioLife Solutions Natus Medical Haemonetics Penumbra Glaukos Bausch + Lomb Inspire Medical Systems PROCEPT BioRobotics CONMED (NYSE:CNMD) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability, community ranking and analyst recommendations. Which has more risk & volatility, CNMD or LIVN? CONMED has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Which has higher earnings and valuation, CNMD or LIVN? CONMED has higher revenue and earnings than LivaNova. CONMED is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCONMED$1.24B1.75$64.46M$4.2116.79LivaNova$1.15B2.36$17.55M$0.42119.17 Is CNMD or LIVN more profitable? CONMED has a net margin of 10.23% compared to LivaNova's net margin of 1.91%. CONMED's return on equity of 13.84% beat LivaNova's return on equity.Company Net Margins Return on Equity Return on Assets CONMED10.23% 13.84% 5.26% LivaNova 1.91%13.81%7.07% Does the MarketBeat Community favor CNMD or LIVN? LivaNova received 357 more outperform votes than CONMED when rated by MarketBeat users. Likewise, 69.20% of users gave LivaNova an outperform vote while only 47.22% of users gave CONMED an outperform vote. CompanyUnderperformOutperformCONMEDOutperform Votes3447.22% Underperform Votes3852.78% LivaNovaOutperform Votes39169.20% Underperform Votes17430.80% Does the media refer more to CNMD or LIVN? In the previous week, LivaNova had 6 more articles in the media than CONMED. MarketBeat recorded 8 mentions for LivaNova and 2 mentions for CONMED. CONMED's average media sentiment score of 0.95 beat LivaNova's score of 0.93 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in CNMD or LIVN? 97.6% of LivaNova shares are owned by institutional investors. 6.8% of CONMED shares are owned by insiders. Comparatively, 0.3% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts recommend CNMD or LIVN? CONMED currently has a consensus price target of $79.80, indicating a potential upside of 12.89%. LivaNova has a consensus price target of $69.17, indicating a potential upside of 38.20%. Given LivaNova's stronger consensus rating and higher possible upside, analysts clearly believe LivaNova is more favorable than CONMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CONMED 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80LivaNova 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryLivaNova beats CONMED on 11 of the 19 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get LivaNova News Delivered to You Automatically Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIVN vs. The Competition Export to ExcelMetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.79B$3.44B$5.06B$8.89BDividend YieldN/A1.70%4.97%4.06%P/E Ratio119.1711.1589.0213.30Price / Sales2.3692.821,207.2881.01Price / Cash11.9347.0339.1736.03Price / Book2.073.966.085.74Net Income$17.55M$92.21M$119.07M$225.93M7 Day Performance-4.34%-3.40%-1.84%-1.32%1 Month Performance-5.15%6.80%-3.65%0.60%1 Year Performance15.16%17.06%31.62%26.23% LivaNova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIVNLivaNova4.1794 of 5 stars$50.22+0.3%$69.17+37.7%+6.8%$2.73B$1.15B119.572,900CNMDCONMED4.8271 of 5 stars$70.57-0.2%$79.80+13.1%-35.1%$2.18B$1.24B16.794,000INMDInMode2.3243 of 5 stars$18.46+1.2%$22.60+22.4%-19.3%$1.55B$492.05M9.86480BLFSBioLife Solutions1.5082 of 5 stars$25.32+1.2%$27.50+8.6%+86.5%$1.17B$143.27M0.00409Analyst ForecastInsider TradeAnalyst RevisionNTUSNatus MedicalN/A$32.96flatN/A+0.0%$1.14B$473.44M89.081,400Analyst ForecastHAEHaemonetics4.925 of 5 stars$86.00+1.3%$107.88+25.4%+2.4%$4.32B$1.31B35.243,657PENPenumbra4.3239 of 5 stars$237.88-0.6%$227.92-4.2%+1.6%$9.13B$1.16B278.144,200Analyst ForecastInsider TradeGKOSGlaukos3.8428 of 5 stars$142.76+0.9%$134.55-5.8%+121.3%$7.87B$360.35M-46.83780Positive NewsBLCOBausch + Lomb2.3996 of 5 stars$19.57+1.0%$20.91+6.8%+23.2%$6.89B$4.15B0.0013,300INSPInspire Medical Systems4.9104 of 5 stars$184.17-0.3%$233.58+26.8%+29.2%$5.52B$624.80M172.781,011Analyst UpgradePositive NewsPRCTPROCEPT BioRobotics1.5867 of 5 stars$93.46+0.8%$89.50-4.2%+180.7%$4.88B$136.19M0.00626 Related Companies and Tools Related Companies CNMD Alternatives INMD Alternatives BLFS Alternatives NTUS Alternatives HAE Alternatives PEN Alternatives GKOS Alternatives BLCO Alternatives INSP Alternatives PRCT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LIVN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
